Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microtransplantation for High Risk AML
NCT01484171Phase 3Unknown
- Sponsor
- 307 Hospital of the People's Liberation Army
- Start
- Aug 2011
- Primary completion
- Aug 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of peripheral blood stem cells in acute myeloid leukemia (AML), sponsored by 307 Hospital of the People's Liberation Army. Status: unknown.
02
Drugs
peripheral blood stem cells
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01484171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01484171.